H5 VLP pandemic influenza vaccine 5 µg [clinicaltrials_resource:ecc4e5c9b49197b72df9d85fe716e926]
intervention [clinicaltrials_vocabulary:intervention]
H5 VLP pandemic influenza vaccine 5 µg [clinicaltrials_resource:ecc4e5c9b49197b72df9d85fe716e926]
Bio2RDF identifier
ecc4e5c9b49197b72df9d85fe716e926
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:ecc4e5c9b49197b72df9d85fe716e926
arm group [clinicaltrials_vocabulary:arm-group]
intervention desc [clinicaltrials_vocabulary:intervention-desc]
0.5 mL, IM, 2 injections 21 days apart
intervention name [clinicaltrials_vocabulary:intervention-name]
H5 VLP pandemic influenza vaccine 5 µg
identifier
clinicaltrials_resource:ecc4e5c9b49197b72df9d85fe716e926
title
H5 VLP pandemic influenza vaccine 5 µg
@en
type
label
H5 VLP pandemic influenza vacc ...... 4e5c9b49197b72df9d85fe716e926]
@en